146 related articles for article (PubMed ID: 34223998)
1. Neurodegenerative proteinopathies associated with neuroinfections.
Danics K; Forrest SL; Kapas I; Erber I; Schmid S; Törő K; Majtenyi K; Kovacs GG
J Neural Transm (Vienna); 2021 Oct; 128(10):1551-1566. PubMed ID: 34223998
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Carter CJ
Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
[TBL] [Abstract][Full Text] [Related]
3. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.
Kovacs GG; Milenkovic I; Wöhrer A; Höftberger R; Gelpi E; Haberler C; Hönigschnabl S; Reiner-Concin A; Heinzl H; Jungwirth S; Krampla W; Fischer P; Budka H
Acta Neuropathol; 2013 Sep; 126(3):365-84. PubMed ID: 23900711
[TBL] [Abstract][Full Text] [Related]
4. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
[TBL] [Abstract][Full Text] [Related]
5. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles.
Pascoal TA; Therriault J; Benedet AL; Savard M; Lussier FZ; Chamoun M; Tissot C; Qureshi MNI; Kang MS; Mathotaarachchi S; Stevenson J; Hopewell R; Massarweh G; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2020 Sep; 143(9):2818-2830. PubMed ID: 32671408
[TBL] [Abstract][Full Text] [Related]
6. Viral Involvement in Alzheimer's Disease.
Sait A; Angeli C; Doig AJ; Day PJR
ACS Chem Neurosci; 2021 Apr; 12(7):1049-1060. PubMed ID: 33687205
[TBL] [Abstract][Full Text] [Related]
7. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
8. On the prevention and treatment of Alzheimer's disease: Control the promoters and look beyond the brain.
Goldstein MR; Cheslock M
Med Hypotheses; 2021 Sep; 154():110645. PubMed ID: 34315048
[TBL] [Abstract][Full Text] [Related]
9. Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.
Arena JD; Smith DH; Lee EB; Gibbons GS; Irwin DJ; Robinson JL; Lee VM; Trojanowski JQ; Stewart W; Johnson VE
Brain; 2020 May; 143(5):1572-1587. PubMed ID: 32390044
[TBL] [Abstract][Full Text] [Related]
10. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
[TBL] [Abstract][Full Text] [Related]
11. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
[TBL] [Abstract][Full Text] [Related]
14. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
Smith VD; Bachstetter AD; Ighodaro E; Roberts K; Abner EL; Fardo DW; Nelson PT
Brain Pathol; 2018 Mar; 28(2):264-273. PubMed ID: 28281308
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's-related changes in non-demented essential tremor patients vs. controls: links between tau and tremor?
Pan JJ; Lee M; Honig LS; Vonsattel JP; Faust PL; Louis ED
Parkinsonism Relat Disord; 2014 Jun; 20(6):655-8. PubMed ID: 24679899
[TBL] [Abstract][Full Text] [Related]
16. The neuropathological diagnosis of Alzheimer's disease.
DeTure MA; Dickson DW
Mol Neurodegener; 2019 Aug; 14(1):32. PubMed ID: 31375134
[TBL] [Abstract][Full Text] [Related]
17. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
18. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
19. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
20. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
